NCT00097851 2022-06-27
Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)
Cellxpert Biotechnology Corp.
Phase 2 Completed
Cellxpert Biotechnology Corp.
Cellxpert Biotechnology Corp.
Cellxpert Biotechnology Corp.
Progen Pharmaceuticals